Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes

Abstract

People with type 2 diabetes were willing to pay a considerable amount of money each month to lose weight, reduce or avoid hypoglycaemic events and reduce HbA(1C).